Gotowa bibliografia na temat „Tumour suppressor”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Tumour suppressor”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Tumour suppressor"
Wagner, K. J., i S. G. E. Roberts. "Transcriptional regulation by the Wilms' tumour suppressor protein WT1". Biochemical Society Transactions 32, nr 6 (26.10.2004): 932–35. http://dx.doi.org/10.1042/bst0320932.
Pełny tekst źródłaSwale, V. J., i A. G. Quinn. "Tumour suppressor genes". Clinical and Experimental Dermatology 25, nr 3 (maj 2000): 231–35. http://dx.doi.org/10.1046/j.1365-2230.2000.00620.x.
Pełny tekst źródłaCowell, J. K. "Tumour suppressor genes". Annals of Oncology 3, nr 9 (listopad 1992): 693–98. http://dx.doi.org/10.1093/oxfordjournals.annonc.a058319.
Pełny tekst źródłaKLEIN, G. "Tumour suppressor genes". Journal of Cell Science 1988, Supplement 10 (1.02.1988): 171–80. http://dx.doi.org/10.1242/jcs.1988.supplement_10.13.
Pełny tekst źródłaVile, R. "Tumour suppressor genes." BMJ 298, nr 6684 (20.05.1989): 1335–36. http://dx.doi.org/10.1136/bmj.298.6684.1335.
Pełny tekst źródłaMaehama, T., F. Okahara i Y. Kanaho. "The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover". Biochemical Society Transactions 32, nr 2 (1.04.2004): 343–47. http://dx.doi.org/10.1042/bst0320343.
Pełny tekst źródłaClurman, Bruce, i Mark Groudine. "Defining tumour-suppressor genes". Nature 389, nr 6647 (wrzesień 1997): 123. http://dx.doi.org/10.1038/38119.
Pełny tekst źródłaMcCarthy, Nicola. "Surviving the tumour suppressor". Nature Reviews Molecular Cell Biology 8, nr 7 (lipiec 2007): 516. http://dx.doi.org/10.1038/nrm2214.
Pełny tekst źródłaBangham, Jenny. "Tumour-suppressor super models". Nature Reviews Cancer 5, nr 2 (20.01.2005): 84. http://dx.doi.org/10.1038/nrc1554.
Pełny tekst źródłaBangham, Jenny. "Tumour suppressor super models". Nature Reviews Genetics 6, nr 2 (luty 2005): 91. http://dx.doi.org/10.1038/nrg1546.
Pełny tekst źródłaRozprawy doktorskie na temat "Tumour suppressor"
de, Foy K. "Analysis of candidate tumour suppressor genes in sporadic ovarian tumours". Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.598448.
Pełny tekst źródłaLiu, Lu. "Oncogenes and tumour suppressor genes in human central nervous system tumours /". Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3532-7/.
Pełny tekst źródłaDiscenza, Maria Teresa. "Regulation of expression of the Wilms' tumour 1 tumour suppressor gene". Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=82855.
Pełny tekst źródłaWe have identified a novel trans-acting factor, named complex D, which shows sequence specific binding to the WT1 promoter. By electrophoretic mobility shift assays (EMSA), we demonstrate that the transcription factor Sp1 binds the WT1 promoter at a site overlapping the complex D binding site. Molecular mass determination experiments and in situ UV crosslinking indicate that complex D is approximately 130 kDa and consists of at least two proteins. Transient transfection assays show that the integrity of the complex D binding site is necessary for maximal activation of a reporter gene, suggesting that complex D may function as an activator.
Similar to WT1, the ETS-domain transcription factor Pea3 is expressed in tissues where mesenchymal-epithelial interactions occur and both gene products are implicated in regulating the expression of genes necessary for the epithelialization of common organs. Transient transfection assays using WT1 promoter-reporter gene constructs identified a Pea3 responsive element in the WT1 promoter. Overexpression of Pea3 transactivates the WT1 promoter and the presence of the intact Pea3 responsive element is necessary for the transactivation. We demonstrate, by EMSA, the sequence specific binding of Pea3 to the responsive element.
WT1 and the paired box domain transcription factor Paired box 2 (Pax2) are expressed at the initial stages of metanephric kidney development and are critical for the initiation of nephrogenesis. We generated WT1/Pax2 compound heterozygous mutant mice to provide an in vivo model for studying the interplay between WT1 and Pax2 during nephrogenesis. WT1+/-/Pax2 1Neu/+ kidneys were 50% smaller that wild type kidneys and displayed a more severe underdevelopment of the medulla, renal calyces and renal pelvis compared to Pax21Neu/+ kidneys. We demonstrate that WT1 and Pax2 proteins physically interact in vitro and in vivo. Our data suggest that WT1 is a modifier of the Pax2 mutant phenotype and that both proteins may be implicated in a common pathway in the transcriptional network governing metanephric development.
Judson, Hannah. "Investigation of candidate imprinted tumour suppressor genes". Thesis, University of Edinburgh, 2001. http://hdl.handle.net/1842/28316.
Pełny tekst źródłaMancini, DiNardo Debora. "Methylation-mediated inactivation of tumour suppressor genes". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape2/PQDD_0021/NQ58149.pdf.
Pełny tekst źródłaPatel, Anjla Chhotubhai. "The role of fat tumour suppressor gene". Thesis, University of Cambridge, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.619808.
Pełny tekst źródłaMarcar, Lynnette Nongkynrih. "Inhibition of p53 tumour suppressor function by tumour associated MAGE-A proteins". Thesis, University of Dundee, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.521696.
Pełny tekst źródłaBurns, Alice Sin Ying Wai. "The role of the p53 tumour suppressor pathway in central primitive neuroectodermal tumours". Thesis, University of Newcastle Upon Tyne, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.300357.
Pełny tekst źródłaWang, Yemin. "Role of tumour suppressor ING3 in melanoma pathogenesis". Thesis, University of British Columbia, 2009. http://hdl.handle.net/2429/3850.
Pełny tekst źródłaMarston, Nicola Jane. "Mutational analysis of the tumour suppressor protein, p53". Thesis, Imperial College London, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.387679.
Pełny tekst źródłaKsiążki na temat "Tumour suppressor"
The oncogene and tumour suppressor gene factsbook. Wyd. 2. San Diego, Calif: Academic Press, 1997.
Znajdź pełny tekst źródłaPhillips, Stewart Mark Anthony. The loss of tumour suppressor genes in prostate cancer. Birmingham: University of Birmingham, 1995.
Znajdź pełny tekst źródłaLecane, Philip Sidney. A study of the p53 tumour suppressor gene in adenovirus transformed human cells. Birmingham: University of Birmingham, 1995.
Znajdź pełny tekst źródłaTammemagi, Martin Carl. Tobacco smoking, p53 tumour suppressor gene alterations, and clinicopathologic features and prognosis in non-small cell lung cancer. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1998.
Znajdź pełny tekst źródłaEl-Deiry, Wafik S. Tumor Suppressor Genes. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592593283.
Pełny tekst źródłaEl-Deiry, Wafik S. Tumor Suppressor Genes. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/1592593291.
Pełny tekst źródłaS, El-Deiry Wafik, red. Tumor suppressor genes. Totowa, N.J: Humana Press, 2003.
Znajdź pełny tekst źródłaRangnekar, Vivek M., red. Tumor Suppressor Par-4. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-80558-6.
Pełny tekst źródłaRangnekar, Vivek M., red. Tumor Suppressor Par-4. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-73572-2.
Pełny tekst źródłaMacdonald, F. Oncogenes and tumor suppressor genes. Oxford: Bios Scientific Publishers, 1991.
Znajdź pełny tekst źródłaCzęści książek na temat "Tumour suppressor"
Lane, D. P., C. Midgley i T. Hupp. "Tumour suppressor genes and molecular chaperones". W Molecular Chaperones, 113–17. Dordrecht: Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-2108-8_14.
Pełny tekst źródłaPiris, Miguel A., Juan C. Martinez, Margarita Sanchez-Beato, Juan F. Garcia, Carmen Bellas, Javier Menarguez, Raquel Villuendas i Emilia Lloret. "Tumour Suppressor Genes in Hodgkin’s Disease". W Etiology of Hodgkin’s Disease, 209–22. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4613-0339-8_17.
Pełny tekst źródłaHollywood, D. P., i N. R. Lemoine. "Growth Factors, Oncogenes and Tumour Suppressor Genes". W Assessment of Cell Proliferation in Clinical Practice, 27–43. Tokyo: Springer Japan, 1992. http://dx.doi.org/10.1007/978-4-431-68287-5_2.
Pełny tekst źródłaEvan, Gerard, Trevor Littlewood, David Hancock, Martin Bennett, Elizabeth Harrington i Abdallah Fanidi. "C-MYC: Oncogene and Tumour Suppressor Gene". W Apoptosis, 63–84. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4757-9217-1_5.
Pełny tekst źródłaHollywood, D. P., i N. R. Lemoine. "Growth Factors, Oncogenes and Tumour Suppressor Genes". W Assessment of Cell Proliferation in Clinical Practice, 27–43. London: Springer London, 1992. http://dx.doi.org/10.1007/978-1-4471-3190-8_2.
Pełny tekst źródłaLefebvre, Karen J., Sarah Assadian, Wissal El-Assaad i Jose G. Teodoro. "Regulation of Angiogenesis by Tumour Suppressor Pathways". W Experimental and Clinical Metastasis, 79–99. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-3685-0_8.
Pełny tekst źródłaSherbet, G. V., i M. S. Lakshmi. "Tumour suppressor genes". W The Genetics of Cancer, 171–82. Elsevier, 1997. http://dx.doi.org/10.1016/b978-012639875-5/50013-3.
Pełny tekst źródłaHesketh, Robin. "Tumour Suppressor Genes". W The Oncogene & Tumour Suppressor Gene Factsbook, 26–30. Elsevier, 1997. http://dx.doi.org/10.1016/b978-012344548-3/50005-4.
Pełny tekst źródłaTavassoli, Mahvash, i Francesco Pezzella. "Oncogenesis and tumour suppression". W Oxford Textbook of Cancer Biology, redaktorzy Francesco Pezzella, Mahvash Tavassoli i David J. Kerr, 136–54. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198779452.003.0011.
Pełny tekst źródłaHesketh, Robin. "Tumour Suppressor Genes Detected in Human Tumours". W The Oncogene & Tumour Suppressor Gene Factsbook, 83–85. Elsevier, 1997. http://dx.doi.org/10.1016/b978-012344548-3/50015-7.
Pełny tekst źródłaStreszczenia konferencji na temat "Tumour suppressor"
Dawoud, M., M. Dawoud, D. Jones, K. Hodivala-Dilke, S. Dreger, C. Chelala, N. Asaad i L. Jones. "Microenvironmental Changes in DCIS: Myoepithelial Cells Change from Tumour Suppressor to Tumour Promoter." W Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-4161.
Pełny tekst źródłaBlagih, J., A. Hock, S. Mason, F. Zani, K. Blyth i K. Vousden. "PO-403 The tumour suppressor P53 as a guardian of immune tolerance and suppression". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.914.
Pełny tekst źródłaBazzichetto, C., F. Conciatori, I. Falcone, F. Cognetti, L. Ciuffreda i M. Milella. "PO-293 Tumour/stroma interactions in colorectal cancer (CRC) models: role of the tumour suppressor PTEN". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.807.
Pełny tekst źródłaOrság, Petr, Hana Pivoňková, Medard Plucnara, Petra Horáková i Miroslav Fojta. "Recognition of 7-deazapurine-substituted binding sites by tumour suppressor p53 protein". W XVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201112427.
Pełny tekst źródłaKünzler, P., CA Seemayer, S. Kuchen, M. Neidhart, M. Pruschy, BA Michel, RE Gay i S. Gay. "THU0104 In vivoandin vitroinvestigations of the tumour suppressor p16 in rheumatoid arthritis". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.981.
Pełny tekst źródłaRussell, RA, E. Dunlop i A. Tee. "PO-102 Understanding the role of the tumour suppressor, FLCN, in renal tumorigenesis". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.143.
Pełny tekst źródłaFurlan, T., K. Sana, J. Guenther, AV Nguyen i J. Troppmair. "PO-217 Tumour suppressor function of the oxidoreductase p66Shc in BRAFV600E-transformed cells". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.252.
Pełny tekst źródłaJaniszewska, J., M. Bodnar, M. Kostrzewska-Poczekaj, K. Bednarek, J. Paczkowska, R. Greenam, K. Szyfter, M. Wierzbicka, M. Jarmuz-Szymczak i M. Giefing. "PO-380 Epigenetically regulated MAF is a new potential tumour suppressor gene in LSCC". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.408.
Pełny tekst źródłaImoto, Issei, Shigeo Haruki, Ken-ich Kozaki, Takeshi Matsui, Hiroshi Kawachi, Shuhei Komatsu, Tomoki Muramatsu, Yutaka Shimada, Tatsuyuki Kawano i Johji Inazawa. "Abstract 3071: Frequent silencing ofprotocadherin 17, a candidate tumour suppressor for esophageal squamous-cell carcinoma". W Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3071.
Pełny tekst źródłaYouness, R., R. Assal, M. Gad i A. Abdel Motaal. "PO-352 Hijacking hepatocellular carcinoma (HCC) tumour progression through restoring TP53/miR-15a/miR-16 tumour suppressor axis by a novel quercetin glycoside". W Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.382.
Pełny tekst źródłaRaporty organizacyjne na temat "Tumour suppressor"
Swafford, D. S., J. Tesfaigzi i S. A. Belinsky. Expression of the p16{sup INK4a} tumor suppressor gene in rodent lung tumors. Office of Scientific and Technical Information (OSTI), grudzień 1995. http://dx.doi.org/10.2172/381388.
Pełny tekst źródłaShyam, E., i P. Reddy. Tumor Suppressors and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, październik 2001. http://dx.doi.org/10.21236/ada403397.
Pełny tekst źródłaShyam, E., i P. Reddy. Tumor Suppressors and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, październik 2002. http://dx.doi.org/10.21236/ada412779.
Pełny tekst źródłaZeremski, Marija. Use of Genetic Suppressor Elements to Identify Potential Breast Tumor Suppressor Genes. Fort Belvoir, VA: Defense Technical Information Center, październik 1999. http://dx.doi.org/10.21236/ada384064.
Pełny tekst źródłaFreeman, Michael. SIRT3 is a Mitochondrial Tumor Suppressor and Genetic Loss Results in a Murine Model for ER/PR-Positive Mammary Tumors Connecting Metabolism and Carcinogenesis Mitochondrial Tumor Suppressor. Revision. Fort Belvoir, VA: Defense Technical Information Center, listopad 2013. http://dx.doi.org/10.21236/ada604003.
Pełny tekst źródłaYu, Xiaochun. Characterize RAP80, a Potential Tumor Suppressor Gene. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2008. http://dx.doi.org/10.21236/ada485136.
Pełny tekst źródłaYu, Xiaochun. Characterize RAP80, a Potential Tumor Suppressor Gene. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2009. http://dx.doi.org/10.21236/ada520785.
Pełny tekst źródłaTomoda, Toshifumi, i Michael E. Barish. Novel Role of Merlin Tumor Suppressor in Autophagy and its Implication in Treating NF2-Associated Tumors. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2014. http://dx.doi.org/10.21236/ada608945.
Pełny tekst źródłaTomoda, Toshifumi, Jr Jhung, Hirota Donald i Yuki. Novel Role of Merlin Tumor Suppressor in Autophagy and its Implication in Treating NF2-Associated Tumors. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2012. http://dx.doi.org/10.21236/ada563285.
Pełny tekst źródłaBarish, Michael E., Toshifumi Tomoda, Akiko Sumitomo i Yuki Hirota. Novel Role of Merlin Tumor Suppressor in Autophagy and its Implication in Treating NF2-Associated Tumors. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2013. http://dx.doi.org/10.21236/ada592192.
Pełny tekst źródła